Substituted naphthylenes for the treatment of non-insulin dependent diabetes mellitus
申请人:Wyeth
公开号:US20030216442A1
公开(公告)日:2003-11-20
This invention provides compounds of formula I, having the structure
1
wherein R
1
, R
4
, A, and Z are as defined in the specification, or a pharmaceutically acceptable salt thereof, that are useful in treating metabolic disorders mediated by insulin resistance or hyperglycemia.
这项发明提供了具有结构的I式化合物,其结构如下:
其中R
1
,R
4
,A和Z如规范中定义,或其药学上可接受的盐,可用于治疗由胰岛素抵抗或高血糖介导的代谢紊乱。